顯示第 113 至 128 項結果，共 129 項
-
Anti-Integrin alpha 4 [Natalizumab] (Ab00716-13.0-BT)
-
Anti-Integrin alpha 4 [Natalizumab] (Ab00716-13.0)
-
Anti-Integrin alpha 4 [Natalizumab] (Ab00716-23.0-BT)
-
Anti-Integrin alpha 4 [Natalizumab] (Ab00716-23.0)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-1.1-BT)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-1.1)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.0-BT)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.0)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.3-BT)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.3)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.6-BS)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.6-BT)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-10.6)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-2.0-BT)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-2.0)
-
Anti-OX40L [R4930 (Oxelumab)] (Ab00536-23.0-BT)